Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives (Q38013237)

27 August 2017

title

Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives (English)

1 reference

Corrigendum to “Depression and epilepsy, pain and psychogenic nonepileptic seizures: Clinical and therapeutic perspectives” [Epilepsy Behav 24/2 (2012) 169–181]

27 August 2017

corrigendum / erratum

1 reference

10.1016/J.YEBEH.2013.12.018

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1016/J.YEBEH.2013.12.018

author

Philippe Ryvlin

11

1 reference

27 August 2017

10

Rochelle Caplan

1 reference

27 August 2017

12

Frank Gilliam

1 reference

27 August 2017

8

Alan E Ettinger

1 reference

27 August 2017

Andres M Kanner

1

1 reference

27 August 2017

Steven C Schachter

2

1 reference

27 August 2017

John J Barry

3

1 reference

27 August 2017

Dale C Hesdorffer

4

1 reference

27 August 2017

Marco Mula

5

1 reference

27 August 2017

Michael Trimble

6

1 reference

27 August 2017

Bruce Hermann

7

1 reference

27 August 2017

David Dunn

9

1 reference

27 August 2017

W Curt LaFrance

13

1 reference

27 August 2017

publication date

1 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

24

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

169-181

1 reference

The Use of Sertraline in Patients with Epilepsy: Is It Safe?

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression in epilepsy. Significance and phenomenology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Course of depression in patients with comorbid anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Patient-validated content of epilepsy-specific quality-of-life measurement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The influence of comorbid depression on quality of life for people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Determinants of quality of life in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The relationship of neuropsychological functioning to quality of life in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Comorbid anxiety as a suicide risk factor among depressed veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression and comorbidity in community-based patients with epilepsy or asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Anxiety in major depression: relationship to suicide attempts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression measures in outcomes research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

An update on antiepileptic drugs and suicide: are there definitive answers yet?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychiatric adverse events during levetiracetam therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression and suicide attempt as risk factors for incident unprovoked seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The repetition of suicidal behavior: a multicenter cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Gabapentin and suicide attempts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Suicidality and divalproex sodium: analysis of controlled studies in multiple indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression and epilepsy: how closely related are they?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Optimizing health outcomes in active epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression in epilepsy: a frequently neglected multifaceted disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Screening for major depression in epilepsy with common self-report depression inventories.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Rapid detection of major depression in epilepsy: a multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Residual symptoms after partial remission: an important outcome in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Treatment of Interictal Depression with Citalopram in Patients with Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Citalopram as treatment of depression in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Effect of doxepin on seizure frequency in depressed epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The treatment of depression in patients with epilepsy. A double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Antidepressant and double antidepressant treatment for the affective disorder of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The road to recovery from depression--don't drive today with yesterday's map.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The cellular neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Vagus nerve stimulation: mood and cognitive effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression in epilepsy: Why aren't we treating?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Multidisciplinary approach to childhood epilepsy: exploring the scientific rationale and practical aspects of implementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychosocial intervention in pediatric epilepsy: a critique of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

famoses: a modular educational program for children with epilepsy and their parents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Preventing depression in adolescents with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Family predictors of psychopathology in children with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Children of Depressed Mothers 1 Year After the Initiation of Maternal Treatment: Findings From the STAR*D-Child Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Predictors of pharmacoresistant epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The presence and clinical implications of depression in a community population of adults with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Risk factors for depression in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Strategies to detect adverse effects of antiepileptic drugs in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression and pain comorbidity: a literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Antiepileptic drugs and psychopathology of epilepsy: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Subjective perception of cognition is related to mood and not performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Self-reported memory problems in everyday activities in patients with epilepsy treated with antiepileptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Cognitive impairment in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

How late-life depression affects cognition: neural mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The effects of epilepsy and its treatments on affect and emotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression and cognitive complaints following mild traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The influence of comorbid depression on seizure severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Antidepressants for the treatment of chronic pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Neurobiology of depression, fibromyalgia and neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

An epidemiologic comparison of pain complaints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depressive and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: a 10-year follow-up of metal industry employees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychobiological differences between depression and somatization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Pain and depression: the egg and the chicken story revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Prevalence of chronic pain after traumatic brain injury: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The epidemiology of pain in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Assessing benefits of the pain center: why some patients regress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychodynamics and psychiatric diagnoses of pseudoseizure subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Differentiating between nonepileptic and epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Update on treatments of psychological nonepileptic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychogenic non-epileptic seizures: a model of their pathogenic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychogenic nonepileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

SCID diagnosis of panic disorder in psychogenic seizure patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychiatric comorbidity and hostility in patients with psychogenic nonepileptic seizures compared with somatoform disorders and healthy controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychopathologies in patients with nonepileptic seizures with and without comorbid epilepsy: how different are they?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychiatric disorders, trauma, and MMPI profile in a Spanish sample of nonepileptic seizure patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychiatric disorders in patients with psychogenic non-epileptic seizures, with and without comorbid epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression in epilepsy is associated with lack of seizure control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychiatric features of children and adolescents with pseudoseizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychogenic seizures: video telemetry observations in 27 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychogenic seizures after head injury in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Paroxysmal nonepileptic events in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Nonepileptic seizures in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Pediatric psychogenic nonepileptic seizures: a study of assessment tools.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

The MOS 36-ltem Short-Form Health Survey (SF-36)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Quality of life in depression: daily life determinants and variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Quality of life perception in patients with intractable epilepsy or pseudoseizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Quality of life in psychogenic nonepileptic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Seizure disorders, depression, and health-related quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Depression and symptoms affect quality of life in psychogenic nonepileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Cognitive behavioral therapy for psychogenic nonepileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Differences in self-reported depressive symptoms between patients with epileptic and psychogenic nonepileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Heterogeneity in psychogenic nonepileptic seizures: understanding the role of psychiatric and neurological factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

MMPI-II personality profiles of patients with psychogenic nonepileptic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Sociodemographics, clinical features, and psychiatric comorbidities of patients with psychogenic nonepileptic seizures: experience at a specialized epilepsy center in Turkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Anxiety and depression in psychogenic movement disorder and non-epileptic seizures: a prospective comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Quality of life outcome is associated with cessation rather than reduction of psychogenic nonepileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

Psychosocial care needs of parents of children with new-onset seizures. 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Depression among chronic pain patients: cognitive-behavioral analysis and effect on rehabilitation outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2012.01.008

1 reference

27 August 2017

1 reference